| Trial | GO44479 |
|---|---|
| Cancer Type | Pancreatic Cancer |
| Hospital(s) | Belfast City Hospital |
| Information | A PHASE II, OPEN-LABEL, MULTICENTER, RANDOMIZED STUDY OF THE EFFICACY AND SAFETY OF ADJUVANT AUTOGENE CEVUMERAN PLUS ATEZOLIZUMAB AND mFOLFIRINOX VERSUS mFOLFIRINOX ALONE IN PATIENTS WITH RESECTED PANCREATIC DUCTAL ADENOCARCINOMA |
| Trial | Precision-Panc |
|---|---|
| Cancer Type | Gastrointestinal and Pancreatic Cancer |
| Hospital(s) | Belfast City Hospital |
| Information | Master Protocol Personalising Treatment For Pancreatic Cancer |
| Trial | PRIMUS-001 |
|---|---|
| Cancer Type | Gastrointestinal and Pancreatic Cancer |
| Hospital(s) | Belfast City Hospital |
| Information | An adaptive phase II study of FOLFOX-A (FOLFOX and nab-paclitaxel) versus AG (nab-paclitaxel and gemcitabine) in patients with metastatic pancreatic cancer, with integrated biomarker evaluation |